David Nikodem
Chief Executive Officer presso ALTHEADX INC
Posizioni attive di David Nikodem
Società | Posizione | Inizio | Fine |
---|---|---|---|
ALTHEADX INC | Director/Board Member | 01/12/2015 | - |
Chief Executive Officer | 01/12/2018 | - | |
INVENTIVA | Corporate Officer/Principal | 01/09/2018 | - |
Sapidus Consulting Group LLC | Corporate Officer/Principal | - | - |
Storia della carriera di David Nikodem
Precedenti posizioni note di David Nikodem
Società | Posizione | Inizio | Fine |
---|---|---|---|
BNP Paribas Securities Corp.
BNP Paribas Securities Corp. Investment Banks/BrokersFinance BNP Paribas Securities Corp. engages in the provision of brokerage services. It offers commercial banking, corporate and institutional banking, asset management, fleet services, and real estate. The company was founded on September 7, 1984 and is headquartered New York, NY. | Trading-Equity | 06/09/2005 | 30/12/2007 |
Blumberg Capital Management LLC
Blumberg Capital Management LLC Investment ManagersFinance Blumberg Capital Management LLC is a hedge fund manager located in New York City. | Analyst-Equity | 01/01/2002 | 31/08/2005 |
Tunitas Therapeutics, Inc.
Tunitas Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tunitas Therapeutics, Inc. develops protein therapeutics for the treatment of allergy. The firm’s therapeutic approach offers the potential for long-lasting treatments with improved efficacy than existing therapies for many serious allergic diseases, such as asthma and food allergy. The company was founded by Nolan H. Sigal and Andrew Saxon in 2008 and is headquartered in San Francisco, CA. | Director/Board Member | 30/09/2015 | - |
CG ONCOLOGY, INC. | Director/Board Member | - | - |
ALZHEON, INC. | Director/Board Member | 01/12/2014 | - |
Independent Dir/Board Member | 01/12/2014 | - | |
Exane Asset Management SA
Exane Asset Management SA Investment ManagersFinance Exane Asset Management SA (Exane AM) is an alternative investment management firm headquartered in Paris, France. The firm was founded in 2001 and is a subsidiary of Exane SA, itself a subsidiary of BNP Paribas SA (EPA: BNP) in France. Exane AM manages a range of long/short equity market neutral funds designed to respond to the varied needs of a diversified European clientele, composed chiefly of institutional investors, multi-fund managers and private banking professionals. | Portfolio Manager-Equities | 01/01/2010 | - |
Formazione di David Nikodem
University of Virginia | Undergraduate Degree |
Georgetown University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 10 |
Francia | 3 |
Posizioni
Director/Board Member | 4 |
Corporate Officer/Principal | 2 |
Analyst-Equity | 1 |
Settori
Health Technology | 6 |
Finance | 4 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
CG ONCOLOGY, INC. | Health Technology |
INVENTIVA | Health Technology |
Aziende private | 7 |
---|---|
BNP Paribas Securities Corp.
BNP Paribas Securities Corp. Investment Banks/BrokersFinance BNP Paribas Securities Corp. engages in the provision of brokerage services. It offers commercial banking, corporate and institutional banking, asset management, fleet services, and real estate. The company was founded on September 7, 1984 and is headquartered New York, NY. | Finance |
AltheaDx, Inc.
AltheaDx, Inc. Pharmaceuticals: MajorHealth Technology AltheaDx, Inc. operates as a commercial stage molecular diagnostics company which specializes in pharmacogenetics. It focuses in depression and anxiety, clinical publications, and IDgenetix testing process. The company was founded by Francois Ferre and Magda Marquet and is headquartered in San Diego, CA. | Health Technology |
Alzheon, Inc.
Alzheon, Inc. BiotechnologyHealth Technology Alzheon, Inc. engages in the provision of medical development. It specializes in treatment for brain health, memory, and aging. It offers ALZ-801, an oral small molecule inhibitor of amyloid formation and neurotoxicity with potential to be a therapy for a genetically defined population of patients with or at high risk for Alzheimer's disease and other neurodegenerative disorders. The company was founded by Martin Tolar in June 2013 and is headquartered in Framingham, MA. | Health Technology |
Blumberg Capital Management LLC
Blumberg Capital Management LLC Investment ManagersFinance Blumberg Capital Management LLC is a hedge fund manager located in New York City. | Finance |
Exane Asset Management SA
Exane Asset Management SA Investment ManagersFinance Exane Asset Management SA (Exane AM) is an alternative investment management firm headquartered in Paris, France. The firm was founded in 2001 and is a subsidiary of Exane SA, itself a subsidiary of BNP Paribas SA (EPA: BNP) in France. Exane AM manages a range of long/short equity market neutral funds designed to respond to the varied needs of a diversified European clientele, composed chiefly of institutional investors, multi-fund managers and private banking professionals. | Finance |
Tunitas Therapeutics, Inc.
Tunitas Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tunitas Therapeutics, Inc. develops protein therapeutics for the treatment of allergy. The firm’s therapeutic approach offers the potential for long-lasting treatments with improved efficacy than existing therapies for many serious allergic diseases, such as asthma and food allergy. The company was founded by Nolan H. Sigal and Andrew Saxon in 2008 and is headquartered in San Francisco, CA. | Health Technology |
Sapidus Consulting Group LLC |
- Borsa valori
- Insiders
- David Nikodem
- Esperienza